Shares of Wockhardt Ltd. rallied 5% to hit an upper circuit at Rs 1,005.70 on 19th September, after the company announced that its investigational drug,...
The Indian pharma company, Wockhardt Ltd, on Wednesday, 29 May, said that the Phase III clinical trial for Zaynich (Zidebactam/Cefepime) is expected to be completed...
On the Bombay Stock Exchange (BSE), Jyothy Labs Ltd, Sun Pharma Advanced Research Company Ltd, Wockhardt Ltd and Ajanta Pharma Ltd are the other gainers...
Wockhardt Ltd. announced that the drugmaker has received approval from the U.S. health regulator, USFDA, for the generic version of Gleevec used for the treatment...